Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Karyopharm Therapeutics (KPTI) Interest & Investment Income (2016 - 2025)

Historic Interest & Investment Income for Karyopharm Therapeutics (KPTI) over the last 13 years, with Q4 2025 value amounting to $607000.0.

  • Karyopharm Therapeutics' Interest & Investment Income fell 5904.18% to $607000.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $2.8 million, marking a year-over-year decrease of 6252.7%. This contributed to the annual value of $2.8 million for FY2025, which is 6252.7% down from last year.
  • Karyopharm Therapeutics' Interest & Investment Income amounted to $607000.0 in Q4 2025, which was down 5904.18% from $553000.0 recorded in Q3 2025.
  • Karyopharm Therapeutics' 5-year Interest & Investment Income high stood at $2.8 million for Q1 2023, and its period low was $55000.0 during Q4 2021.
  • In the last 5 years, Karyopharm Therapeutics' Interest & Investment Income had a median value of $829000.0 in 2022 and averaged $1.2 million.
  • Its Interest & Investment Income has fluctuated over the past 5 years, first crashed by 8611.11% in 2021, then soared by 375000.0% in 2023.
  • Over the past 5 years, Karyopharm Therapeutics' Interest & Investment Income (Quarter) stood at $55000.0 in 2021, then soared by 2325.45% to $1.3 million in 2022, then soared by 88.91% to $2.5 million in 2023, then tumbled by 41.19% to $1.5 million in 2024, then tumbled by 59.04% to $607000.0 in 2025.
  • Its Interest & Investment Income was $607000.0 in Q4 2025, compared to $553000.0 in Q3 2025 and $613000.0 in Q2 2025.